BACKGROUND: Winter-seasonal epidemics of pneumococcal disease provide an opportunity to understand the drivers of incidence. We sought to determine whether seasonality of invasive pneumococcal disease is caused by increased nasopharyngeal transmission of the bacteria or increased susceptibility to invasive infections driven by cocirculating winter respiratory viruses. METHODS: We analyzed pneumococcal carriage and invasive disease data collected from children <7 years old in the Navajo/White Mountain Apache populations between 1996 and 2012. Regression models were used to quantify seasonal variations in carriage prevalence, carriage density, and disease incidence. We also fit a multivariate model to determine the contribution of carriage prevalence and RSV activity to pneumococcal disease incidence while controlling for shared seasonal factors. RESULTS: The seasonal patterns of invasive pneumococcal disease epidemics varied significantly by clinical presentation: bacteremic pneumococcal pneumonia incidence peaked in late winter, whereas invasive nonpneumonia pneumococcal incidence peaked in autumn. Pneumococcal carriage prevalence and density also varied seasonally, with peak prevalence occurring in late autumn. In a multivariate model, RSV activity was associated with significant increases in bacteremic pneumonia cases (attributable percentage, 15.5%; 95% confidence interval [CI], 1.8%-26.1%) but was not associated with invasive nonpneumonia infections (8.0%; 95% CI, -4.8% to 19.3%). In contrast, seasonal variations in carriage prevalence were associated with significant increases in invasive nonpneumonia infections (31.4%; 95% CI, 8.8%-51.4%) but not with bacteremic pneumonia. CONCLUSIONS: The seasonality of invasive pneumococcal pneumonia could be due to increased susceptibility to invasive infection triggered by viral pathogens, whereas seasonality of other invasive pneumococcal infections might be primarily driven by increased nasopharyngeal transmission of the bacteria.
RCT Entities:
BACKGROUND: Winter-seasonal epidemics of pneumococcal disease provide an opportunity to understand the drivers of incidence. We sought to determine whether seasonality of invasive pneumococcal disease is caused by increased nasopharyngeal transmission of the bacteria or increased susceptibility to invasive infections driven by cocirculating winter respiratory viruses. METHODS: We analyzed pneumococcal carriage and invasive disease data collected from children <7 years old in the Navajo/White Mountain Apache populations between 1996 and 2012. Regression models were used to quantify seasonal variations in carriage prevalence, carriage density, and disease incidence. We also fit a multivariate model to determine the contribution of carriage prevalence and RSV activity to pneumococcal disease incidence while controlling for shared seasonal factors. RESULTS: The seasonal patterns of invasive pneumococcal disease epidemics varied significantly by clinical presentation: bacteremic pneumococcal pneumonia incidence peaked in late winter, whereas invasive nonpneumonia pneumococcal incidence peaked in autumn. Pneumococcal carriage prevalence and density also varied seasonally, with peak prevalence occurring in late autumn. In a multivariate model, RSV activity was associated with significant increases in bacteremic pneumonia cases (attributable percentage, 15.5%; 95% confidence interval [CI], 1.8%-26.1%) but was not associated with invasive nonpneumonia infections (8.0%; 95% CI, -4.8% to 19.3%). In contrast, seasonal variations in carriage prevalence were associated with significant increases in invasive nonpneumonia infections (31.4%; 95% CI, 8.8%-51.4%) but not with bacteremic pneumonia. CONCLUSIONS: The seasonality of invasive pneumococcal pneumonia could be due to increased susceptibility to invasive infection triggered by viral pathogens, whereas seasonality of other invasive pneumococcal infections might be primarily driven by increased nasopharyngeal transmission of the bacteria.
Authors: A Sandgren; K Sjostrom; B Olsson-Liljequist; B Christensson; A Samuelsson; G Kronvall; B Henriques Normark Journal: J Infect Dis Date: 2004-02-16 Impact factor: 5.226
Authors: K L O'Brien; M I Walters; J Sellman; P Quinlisk; H Regnery; B Schwartz; S F Dowell Journal: Clin Infect Dis Date: 2000-05-18 Impact factor: 9.079
Authors: Ana Paula de O Menezes; Jailton Azevedo; Mariela C Leite; Leila C Campos; Marcelo Cunha; Maria da Gloria S Carvalho; Mitermayer G Reis; Albert I Ko; Daniel M Weinberger; Guilherme Ribeiro; Joice N Reis Journal: Vaccine Date: 2015-12-29 Impact factor: 3.641
Authors: Tasnee Chonmaitree; Rocio Trujillo; Kristofer Jennings; Pedro Alvarez-Fernandez; Janak A Patel; Michael J Loeffelholz; Johanna Nokso-Koivisto; Reuben Matalon; Richard B Pyles; Aaron L Miller; David P McCormick Journal: Pediatrics Date: 2016-03-28 Impact factor: 7.124
Authors: Joseph A Lewnard; Noga Givon-Lavi; Amit Huppert; Melinda M Pettigrew; Gili Regev-Yochay; Ron Dagan; Daniel M Weinberger Journal: J Infect Dis Date: 2015-12-23 Impact factor: 5.226
Authors: Abdoulie Bojang; James Jafali; Uzochukwu E Egere; Phillip C Hill; Martin Antonio; David Jeffries; Brian M Greenwood; Anna Roca Journal: PLoS One Date: 2015-07-01 Impact factor: 3.240
Authors: Elina Numminen; Claire Chewapreecha; Claudia Turner; David Goldblatt; Francois Nosten; Stephen D Bentley; Paul Turner; Jukka Corander Journal: Sci Rep Date: 2015-06-12 Impact factor: 4.379
Authors: D Tien Nguyen; Rogier Louwen; Karin Elberse; Geert van Amerongen; Selma Yüksel; Ad Luijendijk; Albert D M E Osterhaus; W Paul Duprex; Rik L de Swart Journal: PLoS One Date: 2015-05-13 Impact factor: 3.240
Authors: Jocelyn Chan; Jana Y R Lai; Cattram D Nguyen; Keoudomphone Vilivong; Eileen M Dunne; Audrey Dubot-Pérès; Kimberley Fox; Jason Hinds; Kerryn A Moore; Monica L Nation; Casey L Pell; Anonh Xeuatvongsa; Manivanh Vongsouvath; Paul N Newton; Kim Mulholland; Catherine Satzke; David A B Dance; Fiona M Russell Journal: BMJ Glob Health Date: 2021-06